Progress in myeloma at last.
出版信息
Br Med J. 1978 Jun 24;1(6128):1653-4.
Abstract
摘要
相似文献
1
Progress in myeloma at last.骨髓瘤终于取得了进展。
Br Med J. 1978 Jun 24;1(6128):1653-4.
2
Vincristine in the treatment of multiple myeloma.长春新碱在多发性骨髓瘤治疗中的应用
Haematologica. 1980 Oct;65(5):595-611.
3
[Chemotherapy of multiple myeloma. Review of the recent trials].[多发性骨髓瘤的化疗。近期试验综述]
Recenti Prog Med. 1981 Aug;71(2):141-7.
4
[Therapeutic choices in myeloma].[骨髓瘤的治疗选择]
Stomatol Mediterr. 1988 Oct-Dec;8(4):301-6.
5
Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristics.使用具有细胞周期特异性特征的抗癌药物治疗缓解期的多发性骨髓瘤。
Cancer Treat Rep. 1977 May-Jun;61(3):381-8.
6
"Protracted pulse" chemotherapy for refractory myeloma: a preliminary report.用于难治性骨髓瘤的“延长脉冲”化疗：初步报告。
Eur J Haematol. 1990 Nov;45(5):274-5.
7
Polychemotherapy (COMP) treatment in myeloma patients. A preliminary report.骨髓瘤患者的多药化疗（COMP）治疗。初步报告。
Haematologica. 1983 May-Jun;68(3):381-91.
8
Multiple myeloma: a therapeutic enigma.多发性骨髓瘤：一种治疗难题。
Am J Clin Oncol. 1982 Feb;5(1):13-9.
9
Sequential therapy compared with combination therapy in multiple myeloma.多发性骨髓瘤中序贯疗法与联合疗法的比较
Arch Intern Med. 1975 Jan;135(1):163-71.
10
The current status and future prospects of treatment for multiple myeloma.
Clin Haematol. 1982 Feb;11(1):181-210.
本文引用的文献
1
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.研究报告：美法仑、环磷酰胺、长春新碱、泼尼松和卡氮芥联合化疗多发性骨髓瘤
Cancer. 1974 Feb;33(2):533-8. doi: 10.1002/1097-0142(197402)33:2<533::aid-cncr2820330231>3.0.co;2-z.
2
Plasma cell myeloma. An interpretive review.浆细胞骨髓瘤。一篇解读性综述。
Cancer. 1972 Dec;30(6):1588-94. doi: 10.1002/1097-0142(197212)30:6<1588::aid-cncr2820300626>3.0.co;2-y.
3
4
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.一种多发性骨髓瘤的临床分期系统。测量的骨髓瘤细胞量与初始临床特征、治疗反应及生存情况的相关性。
Cancer. 1975 Sep;36(3):842-54. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u.
5
Expansion of the growth fraction in multiple myeloma with alkylating agents.烷化剂对多发性骨髓瘤中增殖分数的影响。
Blood. 1975 Jan;45(1):119-29.
6
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.使用美法仑、泼尼松、环磷酰胺、长春新碱和卡莫司汀治疗多发性骨髓瘤的生存时间改善：M - 2方案
Am J Med. 1977 Dec;63(6):897-903. doi: 10.1016/0002-9343(77)90543-5.
7
Tumor size, sensitivity to therapy, and design of treatment schedules.肿瘤大小、对治疗的敏感性以及治疗方案的设计。
Cancer Treat Rep. 1977 Oct;61(7):1307-17.
8
Combination therapy for multiple myeloma.
Cancer. 1977 Dec;40(6):2765-71. doi: 10.1002/1097-0142(197712)40:6<2765::aid-cncr2820400602>3.0.co;2-x.
9
Radioimmunoassay for myeloma idiotype.骨髓瘤独特型的放射免疫测定
J Natl Cancer Inst. 1977 Jun;58(6):1553-5. doi: 10.1093/jnci/58.6.1553.
Zotero 插件